Pyogenic liver abscess screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for pyogenic liver abscess. | |||
==Screening== | |||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for pyogenic liver abscess. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 20:39, 22 February 2017
Pyogenic liver abscess Microchapters |
Diagnosis |
Treatment |
Case Studies |
Pyogenic liver abscess screening On the Web |
American Roentgen Ray Society Images of Pyogenic liver abscess screening |
Risk calculators and risk factors for Pyogenic liver abscess screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for pyogenic liver abscess.
Screening
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for pyogenic liver abscess.